# Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer

> **NCT00548821** · PHASE3 · UNKNOWN · sponsor: **National University Hospital, Singapore**

## Conditions studied

- Locally Advanced Cervical Cancer

## Interventions

- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00548821
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548821, "Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00548821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*